Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Boonen

Showing results (121-130 of 257) with videos related to

Pageof 26
Sort By:
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|February 16, 2013
The effect of care pathways for hip fractures: a systematic overview of secondary studiesFabrizio Leigheb, Kris Vanhaecht, Walter Sermeus, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 24, 2005
Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone ClubSteven Boonen, Jean-Jacques Body, Yves Boutsen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2014
Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?Felicia Cosman, Jane A Cauley, Richard Eastell, et al.
Journal of Biomechanics|March 19, 2011
Fast and accurate specimen-specific simulation of trabecular bone elastic modulus using novel beam-shell finite element modelsJef Vanderoost, Siegfried V N Jaecques, Georges Van der Perre, et al.
Bone|March 24, 2005
Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat modelKatrien Venken, Steven Boonen, Erik Van Herck, et al.
Calcified Tissue International|April 12, 2011
Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiencyStuart H Ralston, Neil Binkley, Steven Boonen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 22, 2011
Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2-year results from a randomized trialSteven Boonen, Jan Van Meirhaeghe, Leonard Bastian, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 3, 2012
Differing risk profiles for individual fracture sites: evidence from the Global Longitudinal Study of Osteoporosis in Women (GLOW)Gordon FitzGerald, Steven Boonen, Juliet E Compston, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 5, 2011
Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture TrialJane A Cauley, Dennis Black, Steven Boonen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 8, 2009
Potential mediators of the mortality reduction with zoledronic acid after hip fractureCathleen S Colón-Emeric, Peter Mesenbrink, Kenneth W Lyles, et al.
Pageof 26

Showing results (121-130 of 257) with videos related to

Sort By:
Pageof 26
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|February 16, 2013
The effect of care pathways for hip fractures: a systematic overview of secondary studiesFabrizio Leigheb, Kris Vanhaecht, Walter Sermeus, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 24, 2005
Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone ClubSteven Boonen, Jean-Jacques Body, Yves Boutsen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2014
Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?Felicia Cosman, Jane A Cauley, Richard Eastell, et al.
Journal of Biomechanics|March 19, 2011
Fast and accurate specimen-specific simulation of trabecular bone elastic modulus using novel beam-shell finite element modelsJef Vanderoost, Siegfried V N Jaecques, Georges Van der Perre, et al.
Bone|March 24, 2005
Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat modelKatrien Venken, Steven Boonen, Erik Van Herck, et al.
Calcified Tissue International|April 12, 2011
Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiencyStuart H Ralston, Neil Binkley, Steven Boonen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 22, 2011
Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2-year results from a randomized trialSteven Boonen, Jan Van Meirhaeghe, Leonard Bastian, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 3, 2012
Differing risk profiles for individual fracture sites: evidence from the Global Longitudinal Study of Osteoporosis in Women (GLOW)Gordon FitzGerald, Steven Boonen, Juliet E Compston, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 5, 2011
Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture TrialJane A Cauley, Dennis Black, Steven Boonen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 8, 2009
Potential mediators of the mortality reduction with zoledronic acid after hip fractureCathleen S Colón-Emeric, Peter Mesenbrink, Kenneth W Lyles, et al.
Pageof 26